- FDA approves weight loss drug Zepbound to treat obstructive sleep apnea NPR
- FDA Approves First Medication for Obstructive Sleep Apnea FDA.gov
- F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The New York Times
- FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity Investors | Eli Lilly and Company
- FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea ABC News